Rolf Ljung

Seniorprofessor
Fler filtreringsmöjligheter
  1. 2021
  2. Practical considerations for nonfactor-replacement therapies in the treatment of haemophilia with inhibitors

    Victor Jiménez-Yuste, Günter Auerswald, Gary Benson, Gerry Dolan, Cedric Hermans, Thierry Lambert, Rolf Ljung, Massimo Morfini, Elena Santagostino & Silva Zupančić Šalek, 2021 mar, I: Haemophilia.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  3. Principles of Care for Acquired Hemophilia

    Gerry Dolan, Gary Benson, Annette Bowyer, Hermann Eichler, Cedric Hermans, Victor Jiménez-Yuste, Rolf Ljung, Debra Pollard, Elena Santagostino & Silva Zupančić Šalek, 2021 feb 1, I: European Journal of Haematology.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Droplet digital PCR and mile-post analysis for the detection of F8 int1h inversions

    Eric Manderstedt, Christina Lind-Halldén, Rolf Ljung, Jan Astermark & Christer Halldén, 2021, I: Journal of Thrombosis and Haemostasis. 19, 3, s. 732-737

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study

    Christoph Male, Nadine G Andersson, Anne Rafowicz, Ri Liesner, Karin Kurnik, Kathelijn Fischer, Helen Platokouki, Elena Santagostino, Hervé Chambost, Beatrice Nolan, Christoph Königs, Gili Kenet, Rolf Ljung, Marijke van den Berg & PedNet Study Group PedNet Study Group, 2021, I: Haematologica. 106, 1, s. 123-129

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. 2020
  7. Novel F8 and F9 gene variants from the PedNet Hemophilia Registry classified according to ACMG/AMP guidelines

    Nadine G Andersson, Veerle Labarque, Anna Letelier, Maria Elisa Mancuso, Martina Bührlen, Kathelijn Fischer, Mutlu Kartal-Kaess, Minna Koskenvuo, Torben Mikkelsen, Rolf Ljung & PedNet Study Group PedNet Study Group, 2020 dec, I: Human Mutation. 41, 12, s. 2058-2072 15 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Detection of mosaics in hemophilia A by deep Ion Torrent sequencing and droplet digital PCR

    Eric Manderstedt, Rosanna Nilsson, Rolf Ljung, Christina Lind-Halldén, Jan Astermark & Christer Halldén, 2020 okt, I: Research and practice in thrombosis and haemostasis. 4, 7, s. 1121-1130 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Long-term follow-up of neonatal intracranial haemorrhage in children with severe haemophilia

    Nadine G Andersson, Runhui Wu, Manuel Carcao, Ségolène Claeyssens-Donadel, Rainer Kobelt, Ri Liesner, Anne Mäkipernaa, Susanna Ranta, Rolf Ljung & ICH study group ICH study group, 2020 jul, I: British Journal of Haematology. 190, 2, s. e101-e104 4 s.

    Forskningsoutput: TidskriftsbidragLetter

  10. Continued benefit demonstrated with BAY 81-8973 prophylaxis in previously treated children with severe haemophilia A: Interim analysis from the LEOPOLD Kids extension study

    Gili Kenet, Rolf Ljung, Luminita Rusen, Bryce A Kerlin, Victor Blanchette, Sonata Saulytė Trakymienė, Valentina Uscatescu, Horst Beckmann, Despina Tseneklidou-Stoeter & Nikki Church, 2020 maj, I: Thrombosis Research. 189, s. 96-101 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Detection of F8 int22h inversions using digital droplet PCR and mile-post assays

    Eric Manderstedt, Christina Lind-Halldén, Rolf Ljung, Jan Astermark & Christer Halldén, 2020 maj, I: Journal of Thrombosis and Haemostasis. 18, 5, s. 1039-1049 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Registries and databases: A European perspective

    Rolf C R Ljung, 2020 apr, I: Haemophilia. 26 , Suppl 3, s. 26-28 2 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Genetic screening of children with suspected inherited bleeding disorders

    Nadine Andersson, Maria Rossing, Marcus Fager Ferrari, Migle Gabrielaite, Eva Leinøe, Rolf Ljung, Annika Mårtensson, Eva Norström & Eva Zetterberg, 2020, I: Haemophilia. 26, 2, s. 314-324 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. 2019
  15. Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A

    H Marijke van den Berg, Kathelijn Fischer, Manuel Carcao, Hervé Chambost, Gili Kenet, Karin Kurnik, Chris Königs, Christoph Male, Elena Santagostino, Rolf Ljung & PedNet Study Group PedNet Study Group, 2019 jul 18, I: Blood. 134, 3, s. 317-320 4 s.

    Forskningsoutput: TidskriftsbidragLetter

  16. Targeted re-sequencing of F8, F9 and VWF: Characterization of Ion Torrent data and clinical implications for mutation screening

    Eric Manderstedt, Rosanna Nilsson, Christina Lind-Halldén, Rolf Ljung, Jan Astermark & Christer Halldén, 2019 apr 26, I: PLoS ONE. 14, 4, e0216179.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication, and strategies for difficult-to-treat patients

    Rolf Ljung, Guenter Auerswald, Gary Benson, Gerry Dolan, Anne Duffy, Cedric Hermans, Victor Jiménez-Yuste, Thierry Lambert, Massimo Morfini, Silva Zupančić-Šalek & Elena Santagostino, 2019 feb, I: European Journal of Haematology. 102, 2, s. 111-122

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  18. Mode of delivery in hemophilia: Vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds

    Nadine G Andersson, Elizabeth A Chalmers, Gili Kenet, Rolf Ljung, Anne Mäkipernaa, Hervé Chambost & PedNet Haemophilia Research Foundation PedNet Haemophilia Research Foundation, 2019, I: Haematologica. 104, 10, s. 2100-2106 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies

    Peter Volkers, Kay-Martin Hanschmann, Thierry Calvez, Hervé Chambost, Peter W Collins, Virginie Demiguel, Daniel P Hart, Charles R M Hay, Jenny Goudemand, Rolf Ljung, Ben P Palmer, Elena Santagostino, Ella M van Hardeveld, Marijke van den Berg & Brigitte Keller-Stanislawski, 2019, I: Haemophilia. 25, 3, s. 398-407

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia: A comparison between intermediate- and high-dose prophylaxis

    Olav Versloot, Erik Berntorp, Pia Petrini, Rolf Ljung, Jan Astermark, Margareta Holmström, Piet de Kleijn & Kathelijn Fischer, 2019, I: Haemophilia. 25, 2, s. 244-251

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. 2018
  22. Practical aspects of extended half-life products for the treatment of haemophilia

    Thierry Lambert, Gary Benson, Gerry Dolan, Cedric Hermans, Victor Jiménez-Yuste, Rolf Ljung, Massimo Morfini, Silva Zupančić-Šalek & Elena Santagostino, 2018 sep, I: Therapeutic advances in hematology. 9, 9, s. 295-308 14 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  23. How I manage patients with inherited haemophilia A and B and factor inhibitors

    Rolf C.R. Ljung, 2018 feb, I: British Journal of Haematology. 180, 4, s. 501-510

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  24. Haemophilia B: Where are we now and what does the future hold?

    Gerry Dolan, Gary Benson, Anne Duffy, Cedric Hermans, Victor Jiménez-Yuste, Thierry Lambert, Rolf Ljung, Massimo Morfini & Silva Zupančić Šalek, 2018 jan, I: Blood Reviews. 32, 1, s. 52-60

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  25. Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management

    Gary Benson, Günter Auerswald, Gerry Dolan, Anne Duffy, Cedric Hermans, Rolf Ljung, Massimo Morfini & Silva Zupančić Šalek, 2018, I: Blood Transfusion. s. 535-544

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  26. Prevention and Management of Bleeding Episodes in Children with Hemophilia

    Rolf C.R. Ljung, 2018, I: Pediatric Drugs. 20, 5, s. 455-464

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. 2017
  28. Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors

    Maria Elisa Mancuso, Kathelijn Fischer, Elena Santagostino, Johannes Oldenburg, Helen Platokouki, Carmen Escuriola-Ettingshausen, George E Rivard, Ana Rosa Cid, Manuel Carcao, Rolf Ljung, Pia Petrini, Carmen Altisent, Gili Kenet, Karin Kurnik, Günther Auerswald, Hérvè Chambost, Anne Mäkipernaa, Angelo Claudio Molinari, Mike Williams, H Marijke van den Berg & 1 andra, European Pediatric Network for Haemophilia Management (PedNet) the REMAIN (REal life MAnagement of children with INhibitors) Study Group European Pediatric Network for Haemophilia Management (PedNet) the REMAIN (REal life MAnagement of children with INhibitors) Study Group, 2017 dec, I: Thrombosis and Haemostasis. 117, 12, s. 2274-2282

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. The care of a child with a newly diagnosed immune thrombocytopenia

    Rolf Ljung, 2017 okt 1, I: Acta Paediatrica, International Journal of Paediatrics. 106, 10, s. 1554-1555

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  30. Outcome measures for adult and pediatric hemophilia patients with inhibitors

    Cedric Hermans, Günter Auerswald, Gary Benson, Gerry Dolan, Anne Duffy, Victor Jiménez-Yuste, Rolf Ljung, Massimo Morfini, Thierry Lambert, Mehdi Osooli & Silva Zupančić Šalek, 2017 aug 1, I: European Journal of Haematology. 99, 2, s. 103-111 9 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  31. Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitors.

    Silva Zupančić Šalek, Günter Auerswald, Gary Benson, Gerry Dolan, Anne Duffy, Cedric Hermans, Victor Jiménez-Yuste, Rolf Ljung, Massimo Morfini, Elena Santagostino & Thierry Lambert, 2017, I: Blood Transfusion. 15, s. 77-84

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B

    K. Kihlberg, K. Strandberg, S. Rosén, R. Ljung & J. Astermark, 2017, I: Haemophilia. 23, 4, s. 620-627

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment

    Nadine Gretenkort Andersson, Günter Auerswald, Chris Barnes, Manuel Carcao, Amy L. Dunn, Karin Fijnvandraat, Marianne Hoffmann, Kaan Kavakli, Gili Kenet, Rainer Kobelt, Karin Kurnik, Ri Liesner, Anne Mäkipernaa, Marilyn J Manco-Johnson, Maria Elisa Mancuso, Angelo Claudio Molinari, Beatrice Nolan, Rosario Perez Garrido, Pia Petrini, Helen E. Platokouki & 3 andra, Amy D. Shapiro, Runhui Wu & Rolf Ljung, 2017, I: British Journal of Haematology. 179, 2, s. 298-307

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Plasma products do not solve the inhibitor problem

    H. M. van den Berg, S. Pipe & R. Ljung, 2017, I: Haemophilia. 23, 3, s. 346-347

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  35. Primary prophylaxis in haemophilia care: Guideline update 2016

    Kathelijn Fischer & Rolf Ljung, 2017, I: Blood Cells, Molecules, and Diseases. 67, s. 81-85

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. 2016
  37. Aspects of prophylactic treatment of hemophilia

    Rolf Ljung, 2016 okt 4, I: Thrombosis Journal. 14, S.1, 30.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  38. Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland

    K. Vepsäläinen, R. Lassila, M. Arola, P. Huttunen, S. Koskinen, R. Ljung, P. Lähteenmäki, M. Möttönen & P. Riikonen, 2016 sep 1, I: Haemophilia. 22, 5, s. 721-729 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. Phenotype and genotype comparisons in carriers of haemophilia A

    A Olsson, R Ljung, M Hellgren, E Berntorp & F Baghaei, 2016 maj, I: Haemophilia. 22, 3, s. 235–237

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Increased inhibitor incidence in severe haemophilia A since 1990 attributable to more low titre inhibitors

    H. Marijke van den Berg, S. Mojtaba Hashemi, Kathelijn Fischer, Pia Petrini, Rolf Ljung, Anne Rafowicz, Manuel Carcao, Günter Auerswald, Karin Kurnik, Gili Kenet & Elena Santagostino, 2016 apr 1, I: Thrombosis and Haemostasis. 115, 4, s. 729-737 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial.

    Rolf Ljung, G Kenet, M E Mancuso, V Kaleva, L Rusen, D Tseneklidou-Stoeter, L A Michaels, A Shah, W Hong & M Maas Enriquez, 2016, I: Haemophilia. 22, 3, s. 354-360

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Evaluating outcome of prophylaxis in haemophilia: objective and self-reported instruments should be combined.

    K Fischer, A Nijdam, M Holmström, P Petrini, Rolf Ljung, Y T van der Schouw & E Berntorp, 2016, I: Haemophilia.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. Origin of mutation in sporadic cases of severe haemophilia A in Sweden.

    Annika Mårtensson, Sten Ivarsson, Anna Letelier, Eric Manderstedt, Christer Halldén & Rolf Ljung, 2016, I: Clinical Genetics. 90, 1, s. 63-68

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. Pain and pain management in haemophilia

    Günter Auerswald, Gerry Dolan, Anne Duffy, Cedric Hermans, Victor Jiménez-Yuste, Rolf Ljung, Massimo Morfini, Thierry Lambert & Silva Zupančić Šalek, 2016, I: Blood Coagulation and Fibrinolysis. 27, 8, s. 845-854

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  45. Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels.

    Rolf Ljung, Kathelijn Fischer, Manuel Carcao, Elena Santagostino, Marilyn J Manco-Johnson & Prasad Mathew, 2016, I: Thrombosis and Haemostasis. 115, 5, s. 913-920

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  46. 2015
  47. Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.

    Annelies Nijdam, Carmen Altisent, Manuel D Carcao, Ana R Cid, Ségolène Claeyssens-Donadel, Karin Kurnik, Rolf Ljung, Beatrice Nolan, Pia Petrini, Helen Platokouki, Anne Rafowicz, Angela E Thomas & Kathelijn Fischer, 2015, I: Haematologica. 100, 3, s. E84-E86

    Forskningsoutput: TidskriftsbidragLetter

  48. Can a "center effect" explain the higher frequency of inhibitors for a second generation recombinant factor VIII product?

    H Marijke van den Berg & Rolf Ljung, 2015, I: Blood. 126, 18, s. 2164-2165

    Forskningsoutput: TidskriftsbidragLetter

  49. Hematologi

    Rolf Ljung, 2015, Neonatologi . Lagercrantz, H., Hellström-Westas, L. & Norman, M. (red.). 2 uppl. Lund: Studentlitteratur AB, s. 237-246 20

    Forskningsoutput: Kapitel i bok/rapport/Conference proceedingKapitel samlingsverk

  50. How to achieve full prophylaxis in young boys with severe haemophilia A: different regimens and their effect on early bleeding and venous access

    A. Nijdam, K. Kurnik, R. Liesner, Rolf Ljung, B. Nolan, P. Petrini & K. Fischer, 2015, I: Haemophilia. 21, 4, s. 444-450

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. Mutation analysis of Swedish haemophilia B families - high frequency of unique mutations.

    Annika Mårtensson, A Letelier, C Halldén & Rolf Ljung, 2015, I: Haemophilia.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  52. Rationale for individualizing haemophilia care.

    Benny Sørensen, Günter Auerswald, Gary Benson, Ivo Elezović, Markus Felder, Thierry Lambert, Massimo Morfini, Eduardo Remor, Peter Salaj, Elena Santagostino, Silva Z Salek & Rolf Ljung, 2015, I: Blood Coagulation and Fibrinolysis. 26, 8, s. 849-857

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  53. Switching treatments in haemophilia: is there a risk of inhibitor development?

    Elena Santagostino, Guenter Auerswald, Gary Benson, Gerry Dolan, Victor Jimenez-Yuste, Thierry Lambert, Rolf Ljung, Massimo Morfini, Eduardo Remor & Silva Zupancic Salek, 2015, I: European Journal of Haematology. 94, 4, s. 284-289

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  54. Tailoring care to haemophilia patients' needs: which specialty and when?

    Massimo Morfini, Gary Benson, Victor Jiménez-Yuste, Rolf Ljung, Pier Mannuccio Mannucci, Gianluigi Pasta, Eduardo Remor & Silva Zupančić Šalek, 2015, I: Blood Transfusion. 13, 4, s. 644-650

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. Various regimens for prophylactic treatment of patients with haemophilia

    Rudolf Schwarz, Rolf Ljung & Ulf Tedgård, 2015, I: European Journal of Haematology. 94, s. 11-16

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  56. 2014
  57. Similar bleeding phenotype in young children with haemophilia A or B: A cohort study

    Rodin Study group Rodin Study group, 2014 nov 1, I: Haemophilia. 20, 6, s. 747-755 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 3 4 5 Nästa